Abstract
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1. Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children. MMWR Morb Mortal Wkly Rep 2000;49:1–55.Centers for Disease Control and PreventionPreventing pneumococcal disease among infants and young children.MMWR Morb Mortal Wkly Rep2000491-552. Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009;360:244–256.HsuHE]]ShuttKA]]MooreMR&etal;Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.N Engl J Med2009360244-2563. Richter SS, Heilmann KP, Dohrn CL, et al. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004–2005. Clin Infect Dis 2009;48:e23–e33.RichterSS]]HeilmannKP]]DohrnCL&etal;Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004–2005.Clin Infect Dis200948e23-e334. Shouval DS, Greenberg D, Givon-Lavi N, et al. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Pediatr Infect Dis J 2009;28:277–282.ShouvalDS]]GreenbergD]]Givon-LaviN&etal;Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.Pediatr Infect Dis J200928277-2825. Lynch JP III, Zhanel GG. Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin Respir Crit Care Med 2009;30:189–209.LynchJPIII]]ZhanelGGStreptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention.Semin Respir Crit Care Med200930189-209